Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1978-05-01
1979-07-03
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435237, A61K 3932
Patent
active
041600240
ABSTRACT:
A vaccine against Marek's disease is produced from a newly isolated Marek's disease virus which is unattenuated and naturally nononcogenic, even in immunosuppressed chickens.
REFERENCES:
patent: 3642574 (1972-02-01), Okazaki et al.
patent: 3674861 (1972-07-01), Churchill
patent: 3783098 (1974-01-01), Calnek et al.
patent: 3981771 (1976-09-01), Sevoian
Calnek, et al. Avian Dis. 21(3):346-358, Sep. 1977, Pathogenicity of Low-virulence Marek's Disease Viruses in Normal Versus Immunologically Compromised Chickens.
Rispens et al., Avian Dis. 16(1):108-138 Apr. 1972, Control of Marek's Disease in the Netherlands I-II Isolation of an Avirulent Marek's Disease Virus (Strain CV1988).
Calnek Bruce W.
Schat Karel A.
Cornell Research Foundation Inc.
Rose Shep K.
LandOfFree
Marek's disease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Marek's disease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marek's disease vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2274736